Analysts Set Metagenomi, Inc. (NASDAQ:MGX) PT at $15.50
Metagenomi, Inc. (NASDAQ:MGX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year target […]
More Stories
Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) To Go Ex-Dividend on September 30th
Morgan Stanley Emerging Markets Debt Fund, Inc. (NYSE:MSD – Get Free Report) announced a quarterly dividend on Friday, September 20th,...
CarMax (NYSE:KMX) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS
CarMax (NYSE:KMX – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.85 EPS for the...
Aytu BioPharma (NASDAQ:AYTU) Announces Earnings Results, Misses Estimates By $0.37 EPS
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) announced its earnings results on Thursday. The company reported ($0.82) earnings per share...
GAMCO Investors, Inc. (GAMI) To Go Ex-Dividend on September 30th
GAMCO Investors, Inc. (NYSE:GAMI – Get Free Report) announced a dividend on Thursday, September 19th, NASDAQ reports. Investors of record...
Tigo Energy, Inc. (NASDAQ:TYGO) Short Interest Update
Tigo Energy, Inc. (NASDAQ:TYGO – Get Free Report) saw a large decrease in short interest during the month of September....
Upwork Inc. (NASDAQ:UPWK) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Upwork Inc. (NASDAQ:UPWK – Get Free Report) have been given a consensus rating of “Moderate Buy” by the...